Plaque reduction neutralization test
The Plaque reduction neutralization test is used to quantify the titre of neutralising antibody for a virus.
The serum sample or solution of antibody to be tested is diluted and mixed with a viral suspension. This is incubated to allow the the antibody to react with the virus. This is poured over a confluent monolayer of host cells. The surface of the cell layer is covered in a layer of agar or carboxymethyl cellulose to prevent the virus from spreading indiscriminately. The concentration of plaque forming units can be estimated by the number of plaques (regions of infected cells) formed after a few days. Depending on the virus the plaque forming units are measured by microscopic observation, florescent antibodies or specific dyes that react with infected cells.[1]
The concentration of serum to reduce the number of plaques by 50% compared to the serum free virus gives the measure of how much antibody is present or how effective it is. This measurement is denoted as the PRNT50 value.
References
- ^ Schmidt, N J (1976-07). "Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells". Journal of Clinical Microbiology. 4 (1): 61–66. ISSN 0095-1137.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help)